As vaccines have started to be rolled out nationwide (in the U.S.) after their initial media blitz globally over the last week or so, I think it’s time to compile a list of interesting facts and information on what we know – for those paying attention, and doing their own research.
Like always, all of this information is public, and any speculation will be highlighted.
We’re going to primarily concentrate on Moderna’s vaccine and information in this article, as that is the vaccine being rolled out locally in my community – confirmed by NCH Health Care Systems earlier today:
Let’s Cover the Basics
I’ve noticed when it comes to modern medicine, the basics are overlooked, so I wanted to cover some basics:
- History of these Vaccines (and Moderna)
- What is mRNA, how does it work, and why is controversial?
- Moderna’s Vaccine – During the course of it’s development, what were the goals, what were they tested for, what were the placebos for which they’re being compared to?
- What were the results of said goals/trials?
- What is the FDA’s “Emergency Use Authorization?”
History of the Vaccines & Moderna
In April, the Department of Health & Human Services tapped Moderna for partcipation in “Operation Warpspeed.”
April 16: HHS made up to $483 million in support available for Moderna’s candidate vaccine, which began Phase 1 trials on March 16 and received a fast-track designation from FDA. This agreement was expanded on July 26 to include an additional $472 million to support late-stage clinical development, including the expanded Phase 3 study of the company’s mRNA vaccine, which began on July 27th.
Who is Moderna? A rather strange company…
Dating back more than 3 years, Moderna has had significant safety and efficacy concerns with it’s products, as reported by Stat news, a major news outlet dedicated to health information (mainstream in that sector).
Moderna Therapeutics, the most highly valued private company in biotech, has run into troubling safety problems with its most ambitious therapy, STAT has learned — and is now banking on a mysterious new technology to keep afloat its brash promise of reinventing modern medicine.
The company’s history is strange, achieving a valuation of $1 Billion (also known as a “unicorn” company in the valley) faster than any other company to date – including the likes of Uber, Lyft, Dropbox, and many other tech giants. What was Moderna’s secret? At least publicly they claimed:
The company’s premise: Using custom-built strands of messenger RNA, known as mRNA, it aims to turn the body’s cells into ad hoc drug factories, compelling them to produce the proteins needed to treat a wide variety of diseases.
But mRNA is a tricky technology. Several major pharmaceutical companies have tried and abandoned the idea, struggling to get mRNA into cells without triggering nasty side effects.
Bancel has repeatedly promised that Moderna’s new therapies will change the world, but the company has refused to publish any data on its mRNA vehicles, sparking skepticism from some scientists and a chiding from the editors of Nature.
The indefinite delay on the Crigler-Najjar project signals persistent and troubling safety concerns for any mRNA treatment that needs to be delivered in multiple doses, covering almost everything that isn’t a vaccine, former employees and collaborators said.
Other Alarming & Interesting Information
From a more recent article over at Business Insider:
- Moderna Chief Medical Officer Tal Zaks told Axios that the public should not “over-interpret” the vaccine trial results to assume life could go back to normal after adults are vaccinated
- “They do not show that they prevent you from potentially carrying this virus transiently and infecting others,” Zaks told Axios
- While he believes, based on the science, that it’s likely that vaccine does prevent transmission, but said there’s still no solid proof of that yet.
- “I think it’s important that we don’t change behavior solely on the basis of vaccination,” he said.
What’s the point!?!
Let’s quickly summarize… a young company with virtually no track record, not only has a huge valuation (faster than any other in history), after 5 years in business sees NO success with it’s primary product, not only proving to be a failure, but is stopped for safety concerns, then downshifts into the manufacture of vaccines (a “loss leader” as they claim – and 3 years before an outbreak) is then tapped by the government to the tune of $1billion to develop one of these vaccines (using the same mRNA process that proved unsuccessful and dangerous both at the company, and more largely in the scientific and therapeutic development community)?… RIGHT. I. DON’T. BUY IT. – And we can stop there folks… you shouldn’t inject yourself. But of course the fate of the world’s at stake so let’s continue.
Obviously speculation at this point, but with the unearthing of the COMPLETE fraud and ponzi scheme we know Theranos was – we have to ask – can this whole system be trusted? The idea that banks, and venture capitalists have our interests at heart is absolutely a joke, not to mention what seems to clearly be their inability to effectively evaluate investments (as was the case with Theranos). Couple that with the pentagon’s plans for leapfrogging china into the 4th industrial revolution (and the backing of this company back to front by military/government funding) one has to take a step back and ask what is going on.
Additionally, it’s very interesting that it is valued so highly (from a speculators perspective) only to actually receive the massive funding from HHS – a hail mary win for anyone able to predict the future, and would explain it’s downshift into the “unprofitable” market of vaccines. Yes, I’m wrestling with the idea the whole thing (COVID) is a project.
I always find it interesting to look at where a company gets it’s money/funding. This is quite interesting:
- Abu Dhabi Investment Authority
- Alexandria Venture Investments
- BB Biotech Ventures
- Fidelity Investments
- Julius Baer Group
- Viking Global Investors
- Sequoia Capital (China)
- Pictet Group
- Arrowmark Partners
- Invus Group
- Alexion Pharmaceuticals
- RA Cpital Management
- Wellington Management
- Bill & Melinda Gates Foundation
- Boston Medical Investors
- FLagship Pioneering
For more information on some even crazier connections of Moderna to the current administration, HHS, NIH I highly recommend watching: https://www.bitchute.com/video/oKeazW6HdgI/
In the video Ryan Cristián of The Last American Vagabond (an extremely well respected COMPLETELY independent journalist) points out conflicts of interest and other crazy information about Moderna, including that the NIH signed an agreement with Moderna for vaccine manufacture in DECEMBER 2019!!!!!
More proof of my assertion above – that this was ALL PLANNED!
Before getting back on track, I don’t know anyone that can read the above Stat article, and not question the vaccine – it’s all there if you pay attention – mRNA is akin to reprogramming your cells, it’s been unsuccessful, massive safety concerns, ineffective… why would “medical professionals” be injecting themselves with this stuff (particularly after we get to the studies and safety information). Either people are absolutely retarded, asleep, or someone is on the take.
What is mRNA?
In a very compressed nutshell mRNA is a packet of information that instructs our own cells to do something. Is this complete DNA altering? No, not exactly. Is that a potential? Absolutely, as our DNA is altered from much less, including the food we eat.
It’s history however, as a therapy, is in question, as we saw above (the largest, oldest, most well-funded company in the space effectively failed to get it working previously – with MANY years of work on their primary product – which was for an arguably simpler disorder than SARS-COV-2).
According to Wikipedia and it’s article on mRNA’s use in vaccines:
Before 2020, no mRNA technology platform (drug or vaccine) had been authorized for use in humans, so there was a risk of unknown effects. The 2020 coronavirus pandemic required faster production capability of mRNA vaccines, made them attractive to national health organisations, and led to debate about the type of initial authorization mRNA vaccines should get (including emergency use authorization or expanded access authorization) after the eight-week period of post-final human trials.….
Up until 2020, these mRNA biotech companies had poor results testing mRNA drugs for cardiovascular, metabolic and renal diseases; selected targets for cancer; and rare diseases like Crigler–Najjar syndrome, with most finding that the side-effects of mRNA insertion were too serious. mRNA vaccines for human use have been developed and tested for the diseases rabies, Zika, cytomegalovirus, and influenza, although none of these mRNA vaccines have been licensed. Many large pharmaceutical companies abandoned the technology, while some biotechs re-focused on the less profitable area of vaccines, where the doses would be at lower levels and side-effects reduced.
You’re reading that right – mRNA was effectively abandoned because mRNA was so catastrophic to the underlying animals tested, and with a few exceptions, completely abandoned because of it’s potential effects on humans.
Although the news has cluttered the web with all kinds of information on mRNA as of late (much from all sides bullshit) older articles shed some light on it’s efficacy. Despite it’s claims of being safer and more temporary than full gene editing/DNA editing techniques – the safety concerns have been reported on for years. Case in point, the above STAT article, as well as this article where they flatly admit many companies stopped using due to issues with animals:
And immune reactions to mRNA injections in animals suggested the technique wasn’t as safe as Karikó had hoped.
Let’s dig into this actual vaccine and it’s outcomes.
Here’s the primary Moderna Study:
- Participants will receive 1 intramuscular (IM) injection of 100 microgram (ug) mRNA-1273 or placebo on Day 1 and on Day 29.
- The outcome measure dealing with “protection”: Number of Participants with a First Occurrence of COVID-19 Starting 14 Days after Second Dose of mRNA-1273 [ Time Frame: Day 29 (second dose) up to Day 759 (2 years after second dose) ]
The results & preliminary report:
The 45 enrolled participants received their first vaccination between March 16 and April 14, 2020 (Fig. S1). Three participants did not receive the second vaccination, including one in the 25-μg group who had urticaria on both legs, with onset 5 days after the first vaccination, and two (one in the 25-μg group and one in the 250-μg group) who missed the second vaccination window owing to isolation for suspected Covid-19 while the test results, ultimately negative, were pending. All continued to attend scheduled trial visits. The demographic characteristics of participants at enrollment are provided in Table 1.
3 out of 45 dropped out.
After the first vaccination, solicited systemic adverse events were reported by 5 participants (33%) in the 25-μg group, 10 (67%) in the 100-μg group, and 8 (53%) in the 250-μg group; all were mild or moderate in severity (Figure 1 and Table S2). Solicited systemic adverse events were more common after the second vaccination and occurred in 7 of 13 participants (54%) in the 25-μg group, all 15 in the 100-μg group, and all 14 in the 250-μg group, with 3 of those participants (21%) reporting one or more severe events.
No serious adverse events were noted, and no prespecified trial halting rules were met. As noted above, one participant in the 25-μg group was withdrawn because of an unsolicited adverse event, transient urticaria, judged to be related to the first vaccination.
None of the participants had fever after the first vaccination. After the second vaccination, no participants in the 25-μg group, 6 (40%) in the 100-μg group, and 8 (57%) in the 250-μg group reported fever; one of the events (maximum temperature, 39.6°C) in the 250-μg group was graded severe. (Additional details regarding adverse events for that participant are provided in the Supplementary Appendix.)
Local adverse events, when present, were nearly all mild or moderate, and pain at the injection site was common. Across both vaccinations, solicited systemic and local adverse events that occurred in more than half the participants included fatigue, chills, headache, myalgia, and pain at the injection site. Evaluation of safety clinical laboratory values of grade 2 or higher and unsolicited adverse events revealed no patterns of concern (Supplementary Appendix and Table S3).
If you’d like that translated, a significant portion saw a IMMEDIATE adverse reactions – 33% in the smallest dose, nearly 70% in the mid-tier dose, and 53% in the highest tier and one participant dropped out due to hives/allergic skin reaction.
Let’s square this away with something we’ve been hearing in the news for the last 6-8 weeks – to announce back in November that the vaccine is 95% protective is bogus on a number of levels – not the least of which is that there have been no studies on it’s efficacy (more later). The side effects are not acceptable (“moderate” means you felt very sick, but you did not need ICU and you have not died.). Additionally, there is nothing in the design of the trial to check if the vaccinated are at higher risk for infections/diseases from all causes. Finally, it’s important to point out that all participants in vaccine trials are CAREFULLY selected to be completely free of any/all health concerns (a position in which a majority of the country is unqualified to fulfill). So, any issues arising from a vaccine during a testing phase are likely much more dramatic in the general population than the small test groups administered and monitored.
Important Points to Review About the Above Studies:
VERY small trials. No more than 10 people in each dosage group. There is NO WAY that effectiveness accuracy can be calculated to a tenth of a percent with such small numbers (as was claimed).
COVID-19 Vaccine Trials Are Essentially Pointless
…because they DO NOT tell us if:
- the vaccines can prevent deaths (from SARS-COV-2)
- if they prevent serious COVID-19 complications
- if they prevent/diminish virus transmission between people.
Check out the CNN and BMJ articles below. If this is the case (and it IS what is being reported) what is the point of these vaccine trials? Unless the end goal is something else.
- Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
- Covid-19 vaccine trials won’t tell us if the shots save lives, expert notes – CNN
“…The most advanced trials for coronavirus vaccines cannot tell researchers if the shots will save lives, or even if they’ll prevent serious disease, a drug development expert pointed out Wednesday. The ongoing trials are only designed to show if the vaccines prevent infection — and most infections are mild infections, Peter Doshi, an associate editor at the BMJ medical journal and a drug development specialist at the University of Maryland’s school of pharmacy, said. “I think there are some pretty widely held assumptions about what we are getting out of Phase 3 studies,” Doshi told CNN.” “None of the trials currently under way are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths. Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus,” Doshi wrote in the BMJ.“
“Hospital admissions and deaths from Covid-19 are simply too uncommon in the population being studied for an effective vaccine to demonstrate statistically significant differences in a trial of 30,000 people. The same is true of its ability to save lives or prevent transmission: the trials are not designed to find out.” Four vaccines being developed in the US are in the most advanced, Phase 3 stage of development: those being made by Moderna, Pfizer, AstraZeneca and Johnson & Johnson. They’re “event-driven” trials, meaning that the goal is to keep them going until a certain number of volunteers become infected. If more infections are seen among people who got placebo, or dummy shots, it’s an indication the vaccines prevented infection. But that doesn’t mean the vaccines saved people from serious disease or death, Doshi argued. “Severe illness requiring hospital admission, which happens in only a small fraction of symptomatic Covid-19 cases, would be unlikely to occur in significant numbers in trials,” he wrote.”
“…”People expect that the most severe part of the Covid iceberg — the ICU admissions and hospitalizations and deaths — that’s what a vaccine would put an end to,” he said. But the current trials will just look for early infections. It’s possible to keep these current trials going and add onto them so that they will, eventually, answer the question of whether Covid vaccines save lives and prevent severe disease.”
Additionally here I think it’s important to point out that the FDA’s Emergency Use Authorization (for which these vaccines are being distributed under) DOES NOT MEAN THEY HAVE BEEN REVIEWED/APPROVED. According to the FDA’s own website:
Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA Commissioner may allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by CBRN threat agents when there are no adequate, approved, and available alternatives.
Section 564 of the FD&C Act was amended by the Project Bioshield Act of 2004 and was further amended by the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), the 21st Century Cures Act of 2016, and Public Law 115-92 of 2017.
These are literally, and technically, unapproved, as they are not going through the FDA’s normal processes. I’m sure digging into the people behind Project Bioshield and PAHPRA would yield interesting results (but I digress)….
A failure of a company, backed by big-tech VC firms, banks, The Gates Foundation and DARPA, starts working on the “unprofitable” vaccine segment 3 years ago – signs a mysterious agreement with HHS 4 months before the “outbreak” – and is using a new, not-human tested, but known safety concern tech to role out a vaccine, that isn’t being evaluated for it’s efficacy in ANY way shape or form?
Yes… it’s that crazy.